Filing Flows › International Stem Cell (ISCO) › Operating margin
International Stem Cell (ISCO) operating margin by quarter
International Stem Cell's operating margin was 4.0% in Q3 2025 (third quarter 2025), -2.9 pts from Q2 2025. Over the last 3 quarters it ranged from 2.1% (Q4 2024) to 6.8% (Q2 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | 4.0% | -2.9 pts | — |
| Q2 2025 | 6.8% | +4.7 pts | — |
| Q4 2024 | 2.1% | — | — |
Q3 2025 at a glance
International Stem Cell, Q3 2025: revenue $2.4M (+9% year over year), operating margin 4.0%, net earnings $57K, operating cash flow $49K. The chart follows the revenue to costs, profit and cash.
Questions
What is International Stem Cell's operating margin?
International Stem Cell's operating margin was 4.0% in Q3 2025 (third quarter 2025), -2.9 pts from Q2 2025.
How has International Stem Cell's operating margin changed?
Over the last 3 quarters it ranged from 2.1% (Q4 2024) to 6.8% (Q2 2025).
Q3 2025 results → · How International Stem Cell makes money →